IN VITRO SENSITIZATION OF HUMAN LYMPHOID CELLS TO ANTIGENS ON CULTURED MELANOMA CELLS. I. CULTURE CONDITIONS RESULTING IN AUGMENTED CELL-MEDIATED CYTOTOXICITY.GOLUB SH.1977; CELL. IMMUNOL.; U.S.A.; DA. 1977; VOL. 28; NO 2; PP. 371-378; BIBL. 21 REF.Article

IN VITRO SENSITIZATION OF HUMAN LYMPHOID CELLS TO ANTIGENS ON CULTURED MELANOMA CELLS. II. SENSITIZATION AGAINST MELANOMA-ASSOCIATED ANTIGENS.GOLUB SH.1977; CELL. IMMUNOL.; U.S.A.; DA. 1977; VOL. 28; NO 2; PP. 379-389; BIBL. 29 REF.Article

IN VITRO ASSAYS OF IMMUNOCOMPETENCE IN PATIENTS WITH LUNG CANCER TREATED WITH LEVAMISOLEGOLUB SH; HOLMES EC.1979; CANCER IMMUNOL. IMMUNOTHERAPY; DEU; DA. 1979; VOL. 7; NO 3; PP. 143-149; BIBL. 16 REF.Article

SYSTEMIC ADMINISTRATION OF HUMAN LEUKOCYTE INTERFERON TO MELANOMA PATIENTS. II: CELLULAR EVENTS ASSOCIATED WITH CHANGES IN NATURAL KILLER CYTOTOXICITYGOLUB SH; D'AMORE P; RAINEY M et al.1982; J. NATL. CANCER INST.; ISSN 0027-8874; USA; DA. 1982; VOL. 68; NO 5; PP. 711-717; BIBL. 24 REF.Article

T LYMPHOCYTES SUBSETS IN PATIENTS WITH MALIGNANT MELANOMAKARAVODIN LM; GIULIANO AE; GOLUB SH et al.1981; CANCER IMMUNOL. IMMUNOTHER.; ISSN 0340-7004; DEU; DA. 1981; VOL. 11; NO 4; PP. 251-254; BIBL. 19 REF.Article

CORELATION OF IN VIVO AND IN VITRO ASSAYS OF IMMUNOCOMPETENCE IN CANCER PATIENTSGOLUB SH; O'CONNELL TX; MORTON DL et al.1974; CANCER RES.; U.S.A.; DA. 1974; VOL. 34; NO 8; PP. 1833-1837; BIBL. 16REF.Article

CORRELATION BETWEEN TUMOR BURDEN AND ANTICOMPLEMENTARY ACTIVITY IN SERA FROM CANCER PATIENTSGUPTA RK; GOLUB SH; MORTON DL et al.1979; CANCER IMMUNOL. IMMUNOTHERAPY; DEU; DA. 1979; VOL. 6; NO 2; PP. 63-71; BIBL. 18 REF.Article

SEQUENTIAL EXAMINATION OF LYMPHOCYTE PROLIFERATIVE CAPACITY IN PATIENTS WITH MALIGNANT MELANOMA RECEIVING BCG IMMUNOTHERAPY.GOLUB SH; FORSYTHE AB; MORTON DL et al.1977; INTERNATION. J. CANCER; SWITZ.; DA. 1977; VOL. 19; NO 1; PP. 18-26; ABS. FR.; BIBL. 22 REF.Article

THE USE OF VIABLE FROZEN LYMPHOCYTES FOR STUDIES IN HUMAN TUMOR IMMUNOLOGYGOLUB SH; SULIT HL; MORTON DL et al.1975; TRANSPLANTATION; U.S.A.; DA. 1975; VOL. 19; NO 3; PP. 195-202; BIBL. 13REF.Serial Issue

CELL-MEDIATED IMMUNITY IS DEPRESSED FOLLOWING CARDIOPULMONARY BYPASSROTH JA; GOLUB SH; CUKINGNAN RA et al.1981; ANN. THORAC. SURG.; ISSN 0003-4975; USA; DA. 1981; VOL. 31; NO 4; PP. 350-356; BIBL. 16 REF.Article

IMMUNOLOGIC ASPECTS OF UNKOWN PRIMARY MELANOMAGIULIANO AE; MOSELEY HS; IRIE RF et al.1980; SURGERY; USA; DA. 1980; VOL. 87; NO 1; PP. 101-105; BIBL. 16 REF.Article

LYMPHOCYTE SURFACE MARKERS AND CYTOTOXICITY FOLLOWING CRYOPRESERVATIONCALLERY CD; GOLIGHTLY M; SIDELL N et al.1980; J. IMMUNOL. METHODS; NLD; DA. 1980; VOL. 35; NO 3-4; PP. 213-223; BIBL. 22 REF.Article

EXPRESSION OF HISTOCOMPATIBILITY (HLA) ANTIGENS ON TUMOR CELLS AND NORMAL CELLS FROM PATIENTS WITH MELANOMA.PELLEGRINO MA; FERRONE S; REISFELD RA et al.1977; CANCER; U.S.A.; DA. 1977; VOL. 40; NO 1; PP. 36-41; BIBL. 27 REF.Article

EFFECT OF BACILLUS CALMETTE-GUERIN IMMUNOTHERAPY ON TUMOR ANTIGEN-INDUCED LYMPHOCYTE-STIMULATED PROTEIN SYNTHESIS IN MELANOMA PATIENTSROTH JA; GOLUB SH; HOLMES C et al.1975; SURGERY; U.S.A.; DA. 1975; VOL. 78; NO 1; PP. 66-75; BIBL. 1 P.Article

PROSPECTS FOR THE IMMUNOTHERAPY OF CANCER. I. BASIC CONCEPTS OF TUMOR IMMUNOLOGYPILCH YH; MYERS GH JR; SPARKS FC et al.1975; CURR. PROBL. SURG.; U.S.A.; DA. 1975; PP. 1-46Article

CELLULAR REACTIONS AGAINST BURKITT LYMPHOMA CELLS. I. COLONY INHIBITION WITH EFFECTOR CELLS FROM PATIENTS WITH BURKITT'S LYMPHOMA = REACTIONS CELLULAIRES CONTRE DES CELLULES DE LYMPHOME DE BURKITT. I. INHIBITION DES COLONIES AVEC DES CELLULES EFFECTRICES DE MALADES ATTEINTS DE LYMPHOME DE BURKITTHEWETSON JF; GOLUB SH; KLEIN G et al.1972; INTERNATION. J. CANCER; SWITZ.; DA. 1972; VOL. 10; NO 1; PP. 142-149; ABS. FR.; BIBL. 21REF.Serial Issue

CELLULAR REACTIONS AGAINST BURKITT LYMPHOMA CELLS. II. EFFECTOR CELLS OBTAINED BY ALLOGENIC STIMULATION IN MIXED LEUKOCYTE CULTURES = REACTIONS CELLULAIRES CONTRE LES CELLULES DE LYMPHOME DE BURKITT. II. CELLULES EFFECTRICES OBTENUES PAR STIMULATION ALLOGENEIQUE DANS DES CULTURES MIXTES DE LEUCOCYTESGOLUB SH; HEWETSON JF; SVEDMYR EAJ et al.1972; INTERNATION. J. CANCER; SWITZ.; DA. 1972; VOL. 10; NO 1; PP. 150-156; ABS. FR.; BIBL. 14REF.Serial Issue

INHIBITION OF MITOGEN-INDUCED LYMPHOCYTE PROLIFERATION CORRELATED TO ANTICOMPLEMENTARY ACTIVITY IN SERA FROM MELANOMA PATIENTSGUPTA RK; GOLUB SH; RANGEL DM et al.1979; CANCER IMMUNOL. IMMUNOTHERAPY; DEU; DA. 1979; VOL. 5; NO 4; PP. 221-228; BIBL. 38 REF.Article

PROSPECTS FOR THE IMMUNOTHERAPY OF CANCER. II. CURRENT STATUS OF IMMUNOTHERAPYPILCH YH; MYERS GH JR; SPARKS FC et al.1975; CURR. PROBL. SURG.; U.S.A.; DA. 1975; PP. 1-61; BIBL. 23P.Article

STUDIES ON CYTOTOXICITY GENERATED IN HUMAN MIXED LYMPHOCYTE CULTURES. II: ANTI-K562 EFFECTORS ARE DISTINCT FROM ALLOSPECIFIC CTL AND CAN BE GENERATED FROM NK-DEPLETED T CELLSSEELEY JK; MASUCCI G; POROS A et al.1979; J. IMMUNOL.; USA; DA. 1979; VOL. 123; NO 3; PP. 1303-1311; BIBL. 43 REF.Article

SYSTEMIC ADMINISTRATION OF HUMAN LEUKOCYTE INTERFERON TO MELANOMA PATIENTS. I: EFFECTS ON NATURAL KILLER FUNCTION AND CELL POPULATIONSGOLUB SH; DOREY F; HARA D et al.1982; J. NATL. CANCER INST.; ISSN 0027-8874; USA; DA. 1982; VOL. 68; NO 5; PP. 703-710; BIBL. 23 REF.Article

LYMPHOID CELLS INFILTRATING HUMAN PULMONARY TUMORS: EFFECT OF INTRALESIONAL BCG INJECTIONNIITSUMA M; GOLUB SH; EDELSTEIN R et al.1981; J. NATL. CANCER INST.; ISSN 0027-8874; USA; DA. 1981; VOL. 67; NO 5; PP. 997-1003; BIBL. 32 REF.Article

SERUM-MEDIATED IMMUNOSUPPRESSION IN LUNG CANCERGIULIANO AE; RANGEL D; GOLUB SH et al.1979; CANCER; USA; DA. 1979; VOL. 43; NO 3; PP. 917-924; BIBL. 35 REF.Article

SUCCESSFUL TRANSURETHRAL INTRALESIONAL BCG THERAPY OF A BLADDER MELANOMADEKERNION JB; GOLUB SH; GUPTA RK et al.1975; CANCER; U.S.A.; DA. 1975; VOL. 36; NO 5; PP. 1662-1667; BIBL. 15 REF.Article

HUMAN TUMOR CELLS GROWN IN FETAL CALF SERUM AND HUMAN SERUM: INFLUENCES ON THE TESTS FOR LYMPHOCYTE CYTOTOXICITY, SERUM BLOCKING AND SERUM ARMING EFFECTSSULIT HL; GOLUB SH; IRIE RF et al.1976; INTERNATION. J. CANCER; SWITZ.; DA. 1976; VOL. 17; NO 4; PP. 461-468; ABS. FR.; BIBL. 31 REF.Article